Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Blanco

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Archivos De Bronconeumologia|April 13, 2025
A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)Diego A Rodríguez-Chiaradía, Rodrigo Torres-Castro, Lucilla Piccari, et al.
JACC. Basic to Translational Science|May 6, 2020
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure TrialInes Garcia-Lunar, Isabel Blanco, Leticia Fernández-Friera, et al.
European Journal of Heart Failure|November 20, 2022
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trialAna García-Álvarez, Isabel Blanco, Inés García-Lunar, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2014
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysemaNorbert Weissmann, Borja Lobo, Alexandra Pichl, et al.
Scientific Reports|July 28, 2022
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
European Heart Journal|November 24, 2020
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trialEkkehard Grünig, Alison MacKenzie, Andrew J Peacock, et al.
Scientific Reports|March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2025
Barriers and Facilitators Associated With Delays in the Diagnosis and Treatment of Lupus: A Qualitative Study of Patients and Rheumatologists in the Central American and Caribbean RegionTirsa Colmenares-Roa, Carolina Espinosa-Escobar, Amaranta Manrique de Lara, et al.
The European Respiratory Journal|December 23, 2018
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Christina Eichstaedt, Joan-Albert Barberà, et al.
Environmental Research|August 1, 2016
Challenges and priorities for modelling livestock health and pathogens in the context of climate changeŞeyda Özkan, Andrea Vitali, Nicola Lacetera, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Archivos De Bronconeumologia|April 13, 2025
A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)Diego A Rodríguez-Chiaradía, Rodrigo Torres-Castro, Lucilla Piccari, et al.
JACC. Basic to Translational Science|May 6, 2020
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure TrialInes Garcia-Lunar, Isabel Blanco, Leticia Fernández-Friera, et al.
European Journal of Heart Failure|November 20, 2022
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trialAna García-Álvarez, Isabel Blanco, Inés García-Lunar, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2014
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysemaNorbert Weissmann, Borja Lobo, Alexandra Pichl, et al.
Scientific Reports|July 28, 2022
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
European Heart Journal|November 24, 2020
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trialEkkehard Grünig, Alison MacKenzie, Andrew J Peacock, et al.
Scientific Reports|March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2025
Barriers and Facilitators Associated With Delays in the Diagnosis and Treatment of Lupus: A Qualitative Study of Patients and Rheumatologists in the Central American and Caribbean RegionTirsa Colmenares-Roa, Carolina Espinosa-Escobar, Amaranta Manrique de Lara, et al.
The European Respiratory Journal|December 23, 2018
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Christina Eichstaedt, Joan-Albert Barberà, et al.
Environmental Research|August 1, 2016
Challenges and priorities for modelling livestock health and pathogens in the context of climate changeŞeyda Özkan, Andrea Vitali, Nicola Lacetera, et al.
Pageof 21